Home Antibody All anti-FANCA antibodies
Also for FANCA (NM_000135)
|Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 190 of FACA|
|WB, IHC, IF
||WB:1:500-1:3000; IHC:1:500; IF:1:100-1:200;
|0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.|
|Purified by antigen-affinity chromatography. (Protein A or G Sepharose)
|Homo sapiens Fanconi anemia, complementation group A (FANCA), transcript variant 1|
|FA; FA-H; FA1; FAA; FACA; FAH; FANCH|
|The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq]|
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
A: A431 B: Hela (anti-FANCA antibody diluted at 1:1000)
Immunohistochemical analysis of paraffin-embedded OV90 xenograft, using FACA(anti-FANCA antibody) antibody at 1:500 dilution.
Immunofluorescence analysis of paraformaldehyde-fixed HeLa, using FACA(anti-FANCA antibody) antibody at 1:200 dilution.